News:Biomarkers
Read the latest news about the use of biomarkers in research on Alzheimer's prevention.
Dr. José Luis Molinuevo participates in a paper that recommends informing about beta amyloid as a risk factor for dementia
The vision, which is signed by scientists from international centers, has been published in Lancet Neurology
Scientists identify a protein that could protect against Alzheimer’s disease
Marc Suárez-Calvet, researcher at the BBRC, is a co-author of this study led by University of Munich
BBRC study identifies new reference values of a biomarker of Alzheimer’s disease that could increase the number of participants in prevention strategies
Researchers have determined cut-off values that mark the transition from the absence of amyloid pathology to subtle pathology.
The research community adopts a new biomarker-based definition of Alzheimer’s disease
Dr. José Luís Molinuevo from BBRC is part of the experts’ team that worked on the new research framework for Alzheimer’s disease definition, which has been published in Alzheimer's & Dementia Journal
BBRC researchers participate in the 14th International Conference on Alzheimer’s & Parkinson’s Diseases
Dr José Luis Molinuevo is participating in several sessions of the congress that is taking place in Lisbon, from the 26th to the 31st of March
What is the effect of biological –but not chronological– age, in Alzheimer’s disease?
BBRC researchers have received funding from the Alzheimer’s Association to analyze the possible effect of telomeres, which are considered a biomarker of biological aging, in the disease
BBRC researchers identify cognitive and brain volumetric profile differences in individuals with subjective cognitive decline
The study has detected that some individuals who perceive subjective cognitive decline have a worse cognitive performance and lower grey matter volumes in areas which are affected by Alzheimer’s disease
BBRC launches new study with umbilical cord blood from the Blood and Tissue Bank
The aim of the project, entitled AlfaAge, is to identify pro-ageing and pro-youthful blood biomarkers in different age groups.
BBRC starts BioAlfa, a novel research on cerebral pro-ageing and pro-youthful blood factors
The project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310.
